Sublicensable Patents definition

Sublicensable Patents means patents and patent applications, both U.S. and non-U.S., which relate to CRM Products and which are the subject of licenses or assignments or other agreements with non-Affiliated third parties in force as of the Effective Date and which licenses or assignments or other agreements (a) convey rights to St. Jude or its Affiliates or BSC or its Affiliates as licensee or assignee or grantee, including the right to grant sublicenses or licenses, and further (b) (i) require the payment of royalties or any other continuing payments either for use of the patents or patent applications or to maintain the license or assignment or other agreement in effect or (ii) have other licensing restrictions such as field of use restrictions.
Sublicensable Patents as defined in Section 1.8 of the Agreement: *, *, * and *. EXHIBIT BASSIGNMENT OF PATENT RIGHTS
Sublicensable Patents as to a Party, shall mean all patents owned, acquired, or licensed with the right to sublicense which are licensable or sublicensable (but only in consideration of a royalty or continuing payment to a non-affiliated third party) by such Party (or its Affiliates) as of the Effective Date or subsequent to the Effective Date, and which claim priority, directly or indirectly, to applications filed prior to the Effective Date.

Examples of Sublicensable Patents in a sentence

  • Such sublicenses shall have the same scope and be subject to the same terms and conditions as set forth in Section 2.1, in the case of Chiron Sublicensable Patents claiming HCV or HIV; and shall have the same scope and be subject to the same terms and conditions as set forth in Section 2.2, in the case of other Chiron Sublicensable Patents, in each case to the extent permitted under the terms of the underlying third party license.

  • Following [CONFIDENTIAL TREATMENT REQUESTED], Chiron shall be free to grant any sublicenses under the Chiron Sublicensable Patents to third parties under any terms and conditions, including the granting of exclusive sublicenses.

  • BSC shall defend, indemnify, and hold harmless St. Jude and its Affiliates, and all officers, directors, employees, attorneys, agents, successors, and assigns of St. Jude and its Affiliates, against any and all legal expenses, costs, and judgments arising from any claims, controversies, demands, rights, disputes, grievances, or causes of action that ▇▇▇ ▇▇▇▇▇ and Company asserts relating to the Licensed Patents, the Sublicensable Patents or the ▇▇▇▇▇▇▇▇-Owned Patents.

  • Following [CONFIDENTIAL TREATMENT REQUESTED], CDC shall be free to grant any sublicenses under the CDC Sublicensable Patents to third parties under any terms and conditions, including the granting of exclusive sublicenses.

  • Jude grants (and will cause its Affiliates to grant) to BSC and its Affiliates the right and option until sixty (60) days following the termination of this Agreement to obtain sublicenses under one or more of the Sublicensable Patents.

  • CDC and its Affiliates shall indemnify and defend Chiron against any loss or claim resulting from a breach of an underlying license relating to Chiron Sublicensable Patents based on the acts or omissions of CDC or its Affiliates, Authorized Distributors or permitted sublicensees.

  • Chiron shall indemnify and defend CDC against any loss or claim resulting from a breach of an underlying license relating to CDC Sublicensable Patents based on the acts or omissions of Chiron, its Affiliates or permitted sublicensees.

  • It is the intent of each party to afford the other party and its Affiliates the opportunity to obtain sublicenses under the Sublicensable Patents.

  • Each party shall be responsible for its design, manufacture, instructions for use, quality control, and all safety-related activities relating to its own products, whether or not manufactured under license from the other party’s Licensed Patents or Sublicensable Patents, and shall not be responsible for the products of the other party, the other party’s Affiliates, or any other party or person.

  • The loss of any patent(s) or patent application(s) embraced by the term “Licensed Patents” or “Sublicensable Patents” by any party hereto, through abandonment, failure to renew, declaration of invalidity, or otherwise, shall not be cause to terminate this Agreement or the licenses granted hereunder with respect to all other Licensed Patents or Sublicensable Patents and such loss, or any declaration of noninfringement, invalidity, or unenforceability, shall not be deemed a failure of consideration.


More Definitions of Sublicensable Patents

Sublicensable Patents mean (a) all patents and patent applications identified in Exhibit A as “sublicensable patents”; (b) all reissues, reexaminations, continuations, continuations-in-part, divisionals, renewals and extensions of such patents and patent applications (whether pending, issued, abandoned or filed prior to, on or after the Effective Date); (c) all patents and patent applications (i) to which any or all of the foregoing directly or indirectly claims priority to, or the benefit of, the filing date, or (ii) for which any or all of the foregoing directly or indirectly forms a basis for priority or otherwise provides the benefit of an earlier filing date; and (d) all foreign counterparts to any or all of the foregoing.
Sublicensable Patents means all patents or patents issuing from patent applications in any country, which relate to Cardiac Stimulation Devices and which are the subject of licenses, assignments, options to obtain licenses, or other agreements with third parties in existence as of the Effective Date and which licenses, assignment, options or agreements convey rights to Angeion, as licensee or grantee, to make, use, sell or supply Cardiac Stimulation Devices or components thereof and that include the right to grant sublicenses to third parties. Exhibit 3 is to the best of Angeion's knowledge, information and belief an accurate and complete listing of all Sublicensable Patents subject to licenses, assignments, options to obtain licenses, or other agreements with third parties as of the Effective Date.